RHYTHM’s fully diluted share count & deep in-the-money warrants/convertibles make current market cap & valuation misleadingly ...

The credit quality of the high yield bond market has improved substantially since its inception, particularly after the Great ...

Japan's political uncertainty and economic challenges make broad iShares MSCI Japan ETF investments risky. Click for why ...

The preliminary benchmark revision to March 2024 payrolls has been dramatically revised downward by 911,000 jobs, primarily ...

Boeing ( NYSE: BA) handed over 57 commercial aircraft in August, with its bestselling 737 Max again accounting for the bulk ...

Global Premier Properties Fund returned 1.28% (on a NAV basis) for 3-month period ending 31 July 2025, underperforming the ...

Teck Resources agreed to a stock-for-stock merger with Anglo American. Click here to find out why I think the merger may ...

FB Bancorp stock remains a "Sell" despite recent improvements. Learn more about the bank's profitability and asset quality ...

AstroNova Q2 2026 earnings reveal new CEO-led restructuring, cost reduction goals, and focus on customer retention.

Discover Hello Group's Q2 2025 earnings insights: strong overseas growth, AI-driven innovation, and strategic outlook amid tax and market headwinds.

Chief Financial Officer Mike Santomassimo said the lender still expects to post full-year 2025 net interest income roughly in line with 2024's $47.7B, which compares with the $47.8B Visible Alpha ...

Great. Good morning, everybody. I'm Terence Flynn, Morgan Stanley's large-cap U.S. biopharma analyst. Very pleased to be hosting Amgen this morning. Joining us from the company, we have Peter Griffith ...